Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP511909.RAfvL-VbeRx9FrPcEC6deXGucxgFV0huOT6ohUcFPoBLk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP511909.RAfvL-VbeRx9FrPcEC6deXGucxgFV0huOT6ohUcFPoBLk130_assertion type Assertion NP511909.RAfvL-VbeRx9FrPcEC6deXGucxgFV0huOT6ohUcFPoBLk130_head.
- NP511909.RAfvL-VbeRx9FrPcEC6deXGucxgFV0huOT6ohUcFPoBLk130_assertion description "[In the present study, the anti-cancer effects of GSE were demonstrated in three ESCC cell lines (HKESC-1, HKESC-2 and SLMT-1) by MTS and anchorage-independent clongen-icity assays, expression studies on oncogenes at 11q13 (CCND1, INT2, FGF4 and EMS1) and real-time quantitative telomeric repeat amplification protocol assay to show the inhibitory effect of GSE on telomerase in ESCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP511909.RAfvL-VbeRx9FrPcEC6deXGucxgFV0huOT6ohUcFPoBLk130_provenance.
- NP511909.RAfvL-VbeRx9FrPcEC6deXGucxgFV0huOT6ohUcFPoBLk130_assertion evidence source_evidence_literature NP511909.RAfvL-VbeRx9FrPcEC6deXGucxgFV0huOT6ohUcFPoBLk130_provenance.
- NP511909.RAfvL-VbeRx9FrPcEC6deXGucxgFV0huOT6ohUcFPoBLk130_assertion SIO_000772 17487429 NP511909.RAfvL-VbeRx9FrPcEC6deXGucxgFV0huOT6ohUcFPoBLk130_provenance.
- NP511909.RAfvL-VbeRx9FrPcEC6deXGucxgFV0huOT6ohUcFPoBLk130_assertion wasDerivedFrom befree-20140225 NP511909.RAfvL-VbeRx9FrPcEC6deXGucxgFV0huOT6ohUcFPoBLk130_provenance.
- NP511909.RAfvL-VbeRx9FrPcEC6deXGucxgFV0huOT6ohUcFPoBLk130_assertion wasGeneratedBy ECO_0000203 NP511909.RAfvL-VbeRx9FrPcEC6deXGucxgFV0huOT6ohUcFPoBLk130_provenance.